Inovio: 3Q Earnings Snapshot

Associated Press |

PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Thursday reported a loss of $25 million in its third quarter.

On a per-share basis, the Plymouth Meeting, Pennsylvania-based company said it had a loss of 27 cents.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.

The drugmaker posted revenue of $2 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $2.2 million.

Inovio shares have increased 26 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.19, a decline of nearly 3 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INO at https://www.zacks.com/ap/INO

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Margaux Resources Ltd.

Margaux Resources Ltd is a Calgary based resource company. The Company is focused on its Jersey Emeral Tungsten-Zinc property located in the southeast portion of British Columbia.